Hi KG. Firstly, I thank you and all of our other resident O&G experts for your very informative posts.
Now, I apologise if you or any of our other learned poster have already addressed this, but since last Monday’s sidetrack announcement I have been pondering if the decision to drill MK-2 borehole with a slightly off-vertical trajectory (12 degrees?) and with the slight dog-leg (where the sidetrack is now forking from) was taken as insurance to allow for a more straightforward and optimal vertical sidetrack - in the event that such a contingency would be required.
Could it be that Invictus designed the MK-2 drilling course fully cognizant of the differential sticking risks etc involved in penetrating the LA, yet having a high degree of confidence that any subsequent sidetrack would be relatively straightforward with high probability of successful sample recovery?
- Forums
- ASX - By Stock
- IVZ
- Ann: Mukuyu-2 sidetrack drilling successfully commenced
Ann: Mukuyu-2 sidetrack drilling successfully commenced, page-99
-
- There are more pages in this discussion • 120 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IVZ (ASX) to my watchlist
(20min delay)
|
|||||
Last
7.0¢ |
Change
0.002(2.94%) |
Mkt cap ! $99.25M |
Open | High | Low | Value | Volume |
6.9¢ | 7.0¢ | 6.7¢ | $101.9K | 1.487M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 100000 | 6.9¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
7.0¢ | 354854 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 100000 | 0.069 |
5 | 240973 | 0.068 |
5 | 887635 | 0.067 |
7 | 248441 | 0.066 |
6 | 286432 | 0.065 |
Price($) | Vol. | No. |
---|---|---|
0.070 | 354854 | 3 |
0.071 | 5417 | 1 |
0.073 | 325000 | 2 |
0.074 | 200000 | 2 |
0.075 | 737400 | 5 |
Last trade - 16.10pm 15/07/2024 (20 minute delay) ? |
Featured News
IVZ (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online